DK0533210T3 - Protein C-holdige farmaceutiske præparater som midler mod inflammation. - Google Patents

Protein C-holdige farmaceutiske præparater som midler mod inflammation.

Info

Publication number
DK0533210T3
DK0533210T3 DK92117249.0T DK92117249T DK0533210T3 DK 0533210 T3 DK0533210 T3 DK 0533210T3 DK 92117249 T DK92117249 T DK 92117249T DK 0533210 T3 DK0533210 T3 DK 0533210T3
Authority
DK
Denmark
Prior art keywords
protein
inflammation
agents
pharmaceutical preparations
containing pharmaceutical
Prior art date
Application number
DK92117249.0T
Other languages
English (en)
Inventor
Johann Eibl
Ludwig Pichler
Hans-Peter Schwarz
Original Assignee
Immuno Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno Ag filed Critical Immuno Ag
Application granted granted Critical
Publication of DK0533210T3 publication Critical patent/DK0533210T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/40—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK92117249.0T 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation. DK0533210T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0169790A AT402260B (de) 1990-08-16 1990-08-16 Protein c-hältige pharmazeutische präparation
EP91890012A EP0471660B1 (de) 1990-08-16 1991-01-28 Protein C zur Schmerzbekämpfung

Publications (1)

Publication Number Publication Date
DK0533210T3 true DK0533210T3 (da) 1997-11-03

Family

ID=3519039

Family Applications (3)

Application Number Title Priority Date Filing Date
DK91890012.7T DK0471660T3 (da) 1990-08-16 1991-01-28 Protein C til behandling af smerte
DK92117249.0T DK0533210T3 (da) 1990-08-16 1991-01-28 Protein C-holdige farmaceutiske præparater som midler mod inflammation.
DK92117248.2T DK0533209T3 (da) 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK91890012.7T DK0471660T3 (da) 1990-08-16 1991-01-28 Protein C til behandling af smerte

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK92117248.2T DK0533209T3 (da) 1990-08-16 1991-01-28 Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.

Country Status (12)

Country Link
EP (3) EP0471660B1 (da)
JP (1) JP2530770B2 (da)
AT (6) AT402260B (da)
CA (1) CA2041380C (da)
CZ (1) CZ280004B6 (da)
DE (3) DE59108697D1 (da)
DK (3) DK0471660T3 (da)
ES (3) ES2103861T3 (da)
HR (1) HRP921237A2 (da)
HU (1) HUT60147A (da)
RU (1) RU2066550C1 (da)
YU (1) YU77591A (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571786A (en) * 1990-08-16 1996-11-05 Immuno Aktiengesellschaft Use of protein C or the activation peptide of protein C for preparing a pharmaceutical preparation
AT397615B (de) * 1991-05-14 1994-05-25 Immuno Ag Arzneimittel enthaltend protein c
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
ES2179129T3 (es) * 1995-03-21 2003-01-16 Baxter Ag Agente para la aplicacion subcutanea de la proteina c.
DE19608218A1 (de) * 1995-03-21 1996-09-26 Immuno Ag Mittel zur subkutanen Verabreichung von Protein C
EP1841442A4 (en) * 2005-01-07 2009-12-09 Northern Sydney And Central Co TREATMENT OF AUTOIMMUNE DISEASES AND INFLAMMATORY DISEASES
ES2676422T3 (es) * 2012-07-04 2018-07-19 Zz Biotech Llc Proteína C activada para su uso en el tratamiento de trastornos inflamatorios de la piel
PT3131572T (pt) 2014-04-16 2021-09-24 Zz Biotech Llc Análogo de apc para utilização em cicatrização de feridas
ES2890675T3 (es) 2014-04-16 2022-01-21 Zz Biotech Llc APC para uso en el tratamiento de cicatrices cutáneas anormales

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
US5093117A (en) * 1989-01-24 1992-03-03 Baxter International Inc. Compositions and method for the treatment or prophylaxis of sepsis or septic shock

Also Published As

Publication number Publication date
CA2041380A1 (en) 1992-02-17
HUT60147A (en) 1992-08-28
CS121391A3 (en) 1992-02-19
ATE126699T1 (de) 1995-09-15
EP0471660A2 (de) 1992-02-19
ATA20392A (de) 1997-07-15
HRP921237A2 (en) 1995-10-31
JPH04230633A (ja) 1992-08-19
ATE152354T1 (de) 1997-05-15
ES2080289T3 (es) 1996-02-01
RU2066550C1 (ru) 1996-09-20
ES2103861T3 (es) 1997-10-01
DK0471660T3 (da) 1995-12-18
ATA20492A (de) 1997-10-15
AT403763B (de) 1998-05-25
CZ280004B6 (cs) 1995-09-13
AT403439B (de) 1998-02-25
ATE150649T1 (de) 1997-04-15
EP0533210B1 (de) 1997-05-02
ATA169790A (de) 1996-08-15
EP0471660A3 (en) 1992-04-15
DE59108697D1 (de) 1997-06-05
AT402260B (de) 1997-03-25
DE59108638D1 (de) 1997-04-30
DK0533209T3 (da) 1997-09-22
HU911348D0 (en) 1991-10-28
EP0533210A1 (de) 1993-03-24
JP2530770B2 (ja) 1996-09-04
CA2041380C (en) 1997-10-07
EP0533209B1 (de) 1997-03-26
ES2102435T3 (es) 1997-08-01
EP0533209A1 (de) 1993-03-24
DE59106292D1 (de) 1995-09-28
EP0471660B1 (de) 1995-08-23
YU77591A (sh) 1995-10-24

Similar Documents

Publication Publication Date Title
BG95935A (bg) Метод и средство за приемане на дексмедетомидин директно през кожата
NO862096L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende vevsplasminogenaktivator.
IT1221826B (it) Preparato per uso topico per il trattamento terapeutico dell impotentia coeundi
ES2054098T3 (es) Uso de minoxidilo para la curacion de heridas.
TR24895A (tr) PIRIMIDIN TüREVLERI,BUNLARIN ISTIHSAL EDILMESI VE KULLANILMASI
ES2063186T3 (es) Derivados ftalinida, composicion farmaceutica y uso.
DK0533209T3 (da) Farmaceutisk præparat indeholdende protein C som beta-sympatomimetikum.
NO841542L (no) Fremgangsmaate for fremstilling av terapeutisk aktive indeno-pyridazinon-derivater
FI955260L (fi) Transdermaalisia terapeuttisia systeemejä serotoniiniagonistien antamista varten
FI884721A7 (fi) Fluorijohdannnaisten käyttö varjoaineina
ITMI912509A1 (it) Uso della nimesulide nel trattamento della cataratta
DE3875349D1 (de) Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie.
DK211489A (da) Farmaceutisk praeparat
IT8468196A0 (it) Dispositivo osmotico e procedimento per l erogazione di un agente benefico particolarmente di un farmaco ad un ambiente d uso
FI843155A7 (fi) Indolijohdannaisten valmistus ja terapeuttinen soveltuminen.
NO842821L (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidinon-derivater
FI934468A0 (fi) Bensenborsyraderivat, foerfarande foer deras framstaellning och deras anvaendning som sytesmellanprodukter
ES2011230A4 (es) Derivados peptidos del 3 - aminodihidrotiofeno - 2 - uno, procesos para la preparacion y uso terapeutico
FI924088A0 (fi) Anvaendning av prostaglandin f3a som oegontryck saenkande medel.
FI104232B1 (fi) Hirudiinijohdannaisten käyttö trombiini-inhibiittoreina
NO931914D0 (no) Anvendelse av halogenimider som brannhemmende midler
IT8321398A1 (it) Preparazioni farmaceutiche per trattamento topico della cataratta
BR1100888A (pt) Variantes de ativador de plasminogênios de tecido, composições e métodos de uso da mesma
NO923642D0 (no) Anvendelse av 5-trans-prostaglandin f2alfa som et okulart hypotensivt middel
SE9202013D0 (sv) Saett foer beredning av loesning foer medicinsk anvaendning